» Articles » PMID: 33897680

Immune Subtyping in Latent Tuberculosis

Overview
Journal Front Immunol
Date 2021 Apr 26
PMID 33897680
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Latent tuberculosis infection (LTBI) poses a major roadblock in the global effort to eradicate tuberculosis (TB). A deep understanding of the host responses involved in establishment and maintenance of TB latency is required to propel the development of sensitive methods to detect and treat LTBI. Given that LTBI individuals are typically asymptomatic, it is challenging to differentiate latently infected from uninfected individuals. A major contributor to this problem is that no clear pattern of host response is linked with LTBI, as molecular correlates of latent infection have been hard to identify. In this study, we have analyzed the global perturbations in host response in LTBI individuals as compared to uninfected individuals and particularly the heterogeneity in such response, across LTBI cohorts. For this, we constructed individualized genome-wide host response networks informed by blood transcriptomes for 136 LTBI cases and have used a sensitive network mining algorithm to identify top-ranked host response subnetworks in each case. Our analysis indicates that despite the high heterogeneity in the gene expression profiles among LTBI samples, clear patterns of perturbation are found in the immune response pathways, leading to grouping LTBI samples into 4 different immune-subtypes. Our results suggest that different subnetworks of molecular perturbations are associated with latent tuberculosis.

Citing Articles

Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies.

Dawood S, Natarajan V, Danchaivijitr P Front Oncol. 2024; 14:1374087.

PMID: 38800398 PMC: 11116666. DOI: 10.3389/fonc.2024.1374087.


Active tuberculosis patients have high systemic IgG levels and B-cell fingerprinting, characterized by a reduced capacity to produce IFN-γ or IL-10 as a response to antigens.

Flores-Gonzalez J, Urban-Solano A, Ramon-Luing L, Cancino-Diaz J, Contreras-Rodriguez A, Curiel-Quesada E Front Immunol. 2023; 14:1263458.

PMID: 38022616 PMC: 10643169. DOI: 10.3389/fimmu.2023.1263458.


The Effect of Latent Tuberculosis Infection on Ovarian Reserve and Pregnancy Outcomes among Infertile Women Undergoing Intrauterine Insemination: A Retrospective Cohort Study with Propensity Score Matching.

Chu Y, Chen Y, Yao W, Wang L, Zhang B, Jin L J Clin Med. 2023; 12(19).

PMID: 37835043 PMC: 10573158. DOI: 10.3390/jcm12196398.


Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy.

Gong W, Wu X Front Microbiol. 2021; 12:745592.

PMID: 34745048 PMC: 8570039. DOI: 10.3389/fmicb.2021.745592.

References
1.
Benard A, Sakwa I, Schierloh P, Colom A, Mercier I, Tailleux L . B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis. Am J Respir Crit Care Med. 2017; 197(6):801-813. PMC: 5855072. DOI: 10.1164/rccm.201707-1475OC. View

2.
Serbina N, Flynn J . CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis. Infect Immun. 2001; 69(7):4320-8. PMC: 98502. DOI: 10.1128/IAI.69.7.4320-4328.2001. View

3.
Lin P, Ford C, Coleman M, Myers A, Gawande R, Ioerger T . Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat Med. 2013; 20(1):75-9. PMC: 3947310. DOI: 10.1038/nm.3412. View

4.
DiFazio R, Mattila J, Klein E, Cirrincione L, Howard M, Wong E . Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis. Fibrogenesis Tissue Repair. 2016; 9:6. PMC: 4855369. DOI: 10.1186/s13069-016-0043-3. View

5.
Sambaturu N, Mishra M, Chandra N . EpiTracer - an algorithm for identifying epicenters in condition-specific biological networks. BMC Genomics. 2016; 17 Suppl 4:543. PMC: 5001201. DOI: 10.1186/s12864-016-2792-1. View